Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder

Tina M. Oakes(Eli Lilly (United States)), David Pérahia(École Normale Supérieure Paris-Saclay), Jonna Ahl(Eli Lilly (United States)), Mary Anne Dellva(Eli Lilly (United States)), Christopher Poppe, Karen Waterman(Eli Lilly (United States)), Michael Greenbaum, Céline Goldberger(Eli Lilly (United States))
Current Medical Research and Opinion
April 20, 2015
Cited by 10


Related Papers